TY - JOUR
T1 - Costs of the COPD. Differences between intensive care unit and respiratory intermediate care unit
AU - Bertolini, Guido
AU - Confalonieri, Marco
AU - Rossi, Carlotta
AU - Rossi, Giancarlo
AU - Simini, Bruno
AU - Gorini, Massimo
AU - Corrado, Antonio
AU - Pennacchioni, Silvio
AU - Pecunia, Laura
AU - Franco, Gabriele
AU - Visconti, Maria Grazia
AU - Todesco, Livio
AU - Giannoni, Stafano
AU - Mantovani, Giorgio
AU - Melis, Piergiorgio
AU - Negri, Giovanni
AU - Della Grazia, Laura
AU - Salvi, Giovanni
AU - Trivella, Patrizia
AU - Ciceri, Gabriella
AU - Vianello, Andrea
AU - Villella, Giuseppe
AU - Marchese, Santino
AU - LoCoco, Albino
AU - Potena, Alfredo
AU - Piatella, Marco
AU - Mollica, Corrado
AU - Della Porta, Rossana
AU - Parigi, PierCarlo
PY - 2005/7
Y1 - 2005/7
N2 - Introduction: To assess whether respiratory intermediate care units (RICUs) are cost effective alternatives to intensive care units (ICUs) for patients with exacerbation of chronic obstructive pulmonary disease (COPD). Patients and methods: Multi-centre, prospective, bottom-up cost study performed in 15 ICUs and 6 RICUs. COPD patients staying longer than 48 h were recruited; those coming from other ICUs/RICUs, with immune-deficiency or stroke, were excluded. After the ICU sample was standardised to the RICU distribution of the reason-for-admission and infusion of a vasoactive drug on admission, 60 ICU patients and 65 RICU patients remained, of the original 164 recruited. For each patient, besides clinical data on admission and discharge, daily information about the resources consumed were recorded and analysed in terms of their costs. Results: Total cost per patient was lower in RICUs than in ICUs (754 vs. 1507 Euro; P
AB - Introduction: To assess whether respiratory intermediate care units (RICUs) are cost effective alternatives to intensive care units (ICUs) for patients with exacerbation of chronic obstructive pulmonary disease (COPD). Patients and methods: Multi-centre, prospective, bottom-up cost study performed in 15 ICUs and 6 RICUs. COPD patients staying longer than 48 h were recruited; those coming from other ICUs/RICUs, with immune-deficiency or stroke, were excluded. After the ICU sample was standardised to the RICU distribution of the reason-for-admission and infusion of a vasoactive drug on admission, 60 ICU patients and 65 RICU patients remained, of the original 164 recruited. For each patient, besides clinical data on admission and discharge, daily information about the resources consumed were recorded and analysed in terms of their costs. Results: Total cost per patient was lower in RICUs than in ICUs (754 vs. 1507 Euro; P
KW - Chronic obstructive pulmonary disease
KW - Costs
KW - Intensive care units
KW - Respiratory intermediate care units
UR - http://www.scopus.com/inward/record.url?scp=20444387954&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20444387954&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2004.11.014
DO - 10.1016/j.rmed.2004.11.014
M3 - Article
C2 - 15939252
AN - SCOPUS:20444387954
VL - 99
SP - 894
EP - 900
JO - Respiratory Medicine
JF - Respiratory Medicine
SN - 0954-6111
IS - 7
ER -